One of the ways i2Vision achieved this was by developing a scientific poster: Protective Effects of Two Melanocortin Agonists Delivered by Intravitreal Injection in Mouse Models of Retinopathy. i2Vision’s objective was to investigate the efficacy of two melanocortin agonists in treating mouse models of diabetic retinopathy and Choroidal neovascularization (CNV).

For Palatin’s voice to be heard, i2Vision focused on creating an original design and layout that would stand out in the crowd of posters.